Navigation Links
Positive Picture of Independent Community Pharmacies Emerges With Release of 2008 NCPA Digest, Sponsored by Cardinal Health
Date:10/13/2008

TAMPA, Fla., Oct. 13 /PRNewswire-USNewswire/ -- The 2008 NCPA Digest, sponsored by Cardinal Health, was released today at the NCPA 110th Annual Convention. The Digest has been published annually for over 75 years and provides the most comprehensive portrait of the financial state of independent community pharmacy from the previous calendar year. Last year's Digest provided an inside look into how the Medicare Part D prescription drug program had played a leading role in reducing the number of independent community pharmacies by five percent; but this year's Digest shows how independent community pharmacies are adjusting to new market conditions and are being successful in sustaining their viability.

"Independent community pharmacies are not only valued health care providers, but are remarkably resilient in adjusting to the constantly changing marketplace," said Bruce T. Roberts, RPh, NCPA executive vice president and CEO. "The Digest's numbers demonstrate the business acumen of our more than 23,000 members, as the number of stores stabilized, profit margins improved, and other measurement either showed stability or actual improvement. As a result our patients are better served, which means America is healthier."

In 2007, independent community pharmacies represented an $84 billion share of the marketplace, with $78 billion derived from prescription sales alone. These pharmacies dispensed over 1.4 billion prescription drugs, with an average generic utilization rate of 61 percent, helping to reduce the price of the average prescription drug dispensed at independent community pharmacies by almost $4 from last year. This is an important trend in a health care system that struggles mightily to contain exploding overall costs.

"Significantly reducing health care costs is a goal independent community pharmacies strive to achieve on a daily basis," said Stephen L. Giroux, RPh, NCPA President and an upstate New York pharmacy owner. "This object
'/>"/>

SOURCE National Community Pharmacists Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Cardica to Host Conference Call at 11:00 a.m. Eastern Time Tomorrow to Provide Positive Update on Pas-Port(R)
2. Hummingbird Coaching Services to Speak on Wellness Coaching and Positive Psychology at Medical Wellness Forum
3. Positive Findings Published on Emergent Technology for Treating Chronic Pain
4. New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons TOGETHER Launches Across the Nation
5. Losing weight soon after type 2 diabetes diagnosis doubles positive outcomes
6. Hanger Orthopedic Group, Inc. Receives Positive Outlook from Moodys Investors Service
7. Canadian study of colds and kids: Positive safety results for ginseng extract
8. New Data Highlights Positive Results of Namenda (Memantine HCl) Once-Daily Extended-Release Formulation
9. UK Businesses Urged to Help Employees Deal With Stress More Positively
10. Positive thinking is prescription for the heart
11. Cardiome Announces Positive Phase 2b Results For Oral Vernakalant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ead to new therapies for preterm labor , ... say they,ve found the switch that activates the u...a finding that may lead to therapies for preterm l...ds the protein IP on the surface of these uterine ...ing pregnancy. , But researchers from Dartmout...
(Date:11/21/2008)...a., Nov. 21 During a m...Edward G. Rendell today remembered Lieutenant Gove...an important partner in public service, and a tire... , "As the first woman elected lieutenant gove...vant," said Governor Rendell. "Her family and her ...
(Date:11/21/2008)... Banzel proved effective against Lennox-Gastaut sy...ws) -- A new drug called Banzel (rufinamide) has b...vere form of epilepsy called Lennox-Gastaut syndro...d Friday. , The approval was based on results o...ts ages 4 to 30. Compared to patients who took a p...
(Date:11/21/2008)...lders Intend To Vigorously Protect Investment And ...ov. 21 Dr. Stephen Joff...ndment to their Schedule 13D with the U.S. Securit... filed a 13D disclosing ownership of 11.4% of LCA-...LasikPlus fixed-site laser vision correction cente...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 2Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 3Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 4Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 5Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 6Health News:Founders & Former Executive Management Team of LCA-Vision Seek Change to Rescue Company 7
...loped a micro capsule coated with silicon, which c...ection.This microchip works by absorbing nutrient...ucing cells.Some diabetics have to inject insulin ...r blood sugar levels. The device is being develope...
...e of disability in the United States, affects more...ances in treatment options and educational efforts...d and poorly treated in the US. In fact, a recent ...ns with serious mental illness fail to receive ade...
...hat children have the greatest increase in bone mi...Children who do not take enough exercise are in da...ys the study. Many fail to strengthen up their ske...efore puberty, which is critical to building healt...
...evel electromagnetic fields (EMF) at home could do...national study has found. //The three-year review ...n Non-Ionizing Radiation Protection (ICNIRP) by si...nstitutions around the world. Leukemia, which deve...
Other Medicine News:
(Date:11/19/2008)... a contract development and,manufacturing organiz...st,phase launch of its contract facility in Delaw...he process, facility and capacity problems commonl...ow-volume clinical and,early-stage commercial ste...n invest over $100 million and four years to devel...
(Date:11/18/2008)... make a donation or send a Christmas Seals e-card ...ire/ -- Millions will receive Christmas Seals in t...Association. These decorative holiday stamps are p... to 1907 when the Lung Association led efforts to ... alive today have no vivid memories of how widespr...
(Date:11/18/2008)...luenza survey underscores that mothers need to get...Gold Medalist Kristi Yamaguchi joins initiative ,...e 78 percent of mothers in the United States consi...ening disease that can strike anyone, only half sa...this season, according to a new survey from the Am...
(Date:11/13/2008)...s Prior to Surgery, ARLINGTON HEIGHTS, Ill., Nov....ition before surgery in massive weight loss patien...ease surgical complications, accelerate,wound heal... levels,according to a study in the December issu...ficial medical journal of the American Society of ...
Breaking Medicine Technology:Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Millennium Pharmacy Systems Expands into West Virginia 28877 1Millennium Pharmacy Systems Expands into West Virginia 28877 2LifeMasters Receives Full Accreditation for Disease Management Programs 28872 1LifeMasters Receives Full Accreditation for Disease Management Programs 28872 2LifeMasters Receives Full Accreditation for Disease Management Programs 28872 3Brain recognizes verbal oh dear wave 5738 1Brain recognizes verbal oh dear wave 5738 2Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 1Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 2Americans United for Life Assesses State Ballot Initiative Outcomes Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues 28864 3
...Onset and Total,Sleep Time, and key secondary endp... met at both doses - Evotec to host a,conference c...BURG, Germany | OXFORD, England, June 4, 2007-- Ev...today positive top-line,results from its first pha...hronic primary insomnia. EVT 201 is a partial,posi...
...ebo-controlled Trial,Ever Conducted in CTCL Presen...CHICAGO, June 04, 2007 /PRNewswire/ -- Preliminary...lled clinical trial ever,conducted in patients wit...AK was more than twice as effective as placebo in ...L. [Abstract number 8026],The primary endpoint of ...
Other Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 2Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 3Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 4Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 5Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in,Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL) 6
Vannas Capsulotomy scissors angled forward
Gills-Vannas side angled capsulotomy flat handle scissors
Vannas angled capsulotomy flat handle scissors
No. 1. 30 mm conventional blades. Thin well-rounded tips.
Medicine Products: